TRIANGLE Study: Ibrutinib vs Stem Cell Transplant in Younger Patients With MCL

Boyu Hu, MD, and Bijal D. Shah, MD, provide their thoughts on the TRIANGLE study looking at ibrutinib versus stem cell transplant in MCL.

Related Videos
View All
Related Content